Research of Predictive Factors of in Vitro Fertilization (IVF) Outcome in Women Affected by Autoimmune Disorders: From Biological Markers to Artificial Intelligence

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Infertility is the failure to achieve a clinical pregnancy after 12 months or more of regular unprotected intercourse, while subfertility means a delay in achieving pregnancy. Several factors can contribute to these conditions, such as autoimmune diseases like systemic thyroid and celiac diseases, rheumatoid arthritis, systemic lupus erythematosus, and endometriosis. Some of them may overlap, sharing a common immunological milieu. In this scenario, medically ART can help women carry on pregnancies if they are in stable disease remission and receive adequate treatment. However, the number of oocytes that can be ovulated under stimulation is highly variable, so the outcome of any IVF is linked to many factors, not only biological but also connected to the mean success rate of the fertility center. For these reasons, the need to find methods for identifying the best gametes and embryos to guarantee a successful pregnancy is becoming pressing. AI can be essential to develop prediction models for pregnancy outcomes for patients undergoing ART treatments. AI currently represents a modern way to obtain algorithms from a set of observable data that could help clinical decisions

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Maximum Age: 43
Healthy Volunteers: f
View:

• Women with age below 43 years old

• IVF cycle with fresh semen sample that could be used

• progressive motile spermatozoa expected count of minimum 1 million following density gradient purification on the day of oocyte pick up

Locations
Other Locations
Italy
SSD Ostetricia e Ginecologia 2 - Fondazione IRCCS Policlinico San Matteo, Pavia
RECRUITING
Pavia
Contact Information
Primary
Claudia Omes, PhD
c.omes@smatteo.pv.it
+390382503238
Time Frame
Start Date: 2024-11-22
Estimated Completion Date: 2025-12
Participants
Target number of participants: 200
Treatments
patients with a positive autoimmune panel
Women undergoing ART procedures with a positive autoimmune panel
patients with a negative autoimmune panel
Women undergoing ART procedures with a negative autoimmune panel
Sponsors
Leads: Fondazione IRCCS Policlinico San Matteo di Pavia
Collaborators: Università degli Studi di Pavia

This content was sourced from clinicaltrials.gov